Reaserch Advances on the Role of PI3K/AKT Signaling Pathway and MiRNA in Acute T-Cell Lymphocytic Leukemia--Review / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1344-1347, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-775716
ABSTRACT
Abstract Numerous studies have confirmed that abnormal activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway is one of the most common induction mechanisms of T-ALL. In recent years, many literature report that multiple abnormally expressed microRNAs (miRNAs) can participate in the development of T-ALL by regulating the PI3K/AKT signaling pathway. For example, overexpression of miR-19 and miR181a can activate the PI3K/AKT signaling pathway, which leads to the development of T-ALL and induction of chemotherapy drug resistance, as well as the low expression of miR-26b and miR-29a. Apart from the inhibitors and traditional Chinese medicines that target the PI3K/AKT signaling pathway, regulation of the expression of the corresponding miRNA may also be a potential treatment protocol for T-ALL. The mechanisms of PI3K/AKT signaling pathway involved in the development of T-ALL, the role of miRNAs in the PI3K/AKT signaling pathway and the targeted therapy based on this signaling pathway are summarized briefly in this review.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Leukemia, T-Cell
/
Signal Transduction
/
Phosphatidylinositol 3-Kinases
/
MicroRNAs
/
Proto-Oncogene Proteins c-akt
/
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Type of study:
Practice guideline
Limits:
Humans
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS